Researchers identified five distinct molecular subtypes of Alzheimer’s disease using proteomic sequencing, suggesting personalized treatment approaches based on each subtype’s unique genetic and pathological characteristics.
Pharma budget tightening trickles down to Doximity
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in